Trade Summary

6 days ago, Craig Kevin James, serving as Chief Medical Officer at AtaiBeckley Inc. (ATAI), sold 42,579 shares at $4.51 per share, for a total transaction value of $192,031.29. Following this transaction, Craig Kevin James now holds 8,437 shares of ATAI.

This sale represents a 83.46% decrease in Craig Kevin James's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 25, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 29, 2026 at 6:00 PM ET, 4 days after the trade was made.

AtaiBeckley Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.